tiprankstipranks
Trending News
More News >

Sumitomo Pharma Announces Significant Share Transfer in Asian Business

Story Highlights
Sumitomo Pharma Announces Significant Share Transfer in Asian Business

Don’t Miss TipRanks’ Half-Year Sale

Sumitomo Dainippon Pharma Co ( (JP:4506) ) just unveiled an update.

Sumitomo Pharma Co., Ltd. announced the transfer of its Asian business to a new subsidiary, with 60% of shares being acquired by Marubeni Global Pharma Corporation. This transaction is expected to generate a gain of approximately 45 billion yen, impacting the company’s financial forecast for the fiscal year ending March 2026.

The most recent analyst rating on (JP:4506) stock is a Hold with a Yen460.00 price target. To see the full list of analyst forecasts on Sumitomo Dainippon Pharma Co stock, see the JP:4506 Stock Forecast page.

More about Sumitomo Dainippon Pharma Co

Sumitomo Pharma Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. It has a significant market presence in Asia through its subsidiaries, Sumitomo Pharma (China) Co., Ltd. and Sumitomo Pharma Asia Pacific Pte. Ltd.

Average Trading Volume: 5,624,664

Technical Sentiment Signal: Buy

Current Market Cap: Yen383B

Learn more about 4506 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1